Superficial Bladder Cancer: Drugs or Diathermy?
- 1 March 1986
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 327 (8479) , 479-480
- https://doi.org/10.1016/s0140-6736(86)92934-x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Intravesical Thiotepa and Mitomycin C Treatment Immediately After Transurethral Resection and Later for Superficial (Stages Ta and Tis) Bladder Cancer: A Prospective, Randomized, Stratified Study with Crossover DesignJournal of Urology, 1985
- Adjuvant Chemotherapy of Superficial Transitional Cell Bladder Carcinoma:Preliminary Results of a European Organization for Research onTreatment of Cancer Randomized Trial Comparing Doxorubicin Hydrochloride, Ethoglucid and Transurethral Resection AloneJournal of Urology, 1984
- Does Intravesical Chemotherapy Prevent Invasive Bladder Cancer?Journal of Urology, 1984
- High-Frequency Jet VentilationChest, 1983
- Long-term Fate of 90 Patients with Superficial Bladder Cancer Randomly Assigned to Receive or not to Receive ThiotepaJournal of Urology, 1983
- Lntravesical Instillation of Mitomycin C in the Prophylactic Treatment of Recurring Superficial Transitional Cell Carcinoma of the Bladder*British Journal of Urology, 1983
- A Controlled Trial of Single Dose lntravesical Adriamycin in Superficial Bladder TumoursBritish Journal of Urology, 1981
- Early Multiple‐dose Adjuvant Thiotepa in the Control of Multiple and Rapid TI Tumour NeogenesisBritish Journal of Urology, 1981
- Intravesical Chemotherapy in a Controlled Trial with Thio-Tepa Versus Doxorubicin HydrochlorideJournal of Urology, 1981
- Rationale for Intensive Intravesical Chemotherapy for Superficial Bladder CancerJournal of Urology, 1980